Gene Therapy Player Vera Therapeutics Prices IPO Well Below Range At $11/Share

  • Vera Therapeutics Inc has priced its 4.35 million share IPO at $11 per share, well below its targeted range of $14 to $16, raising $47.58 million in gross proceeds. The biotech will start trading on NASDAQ from Monday under the ticker “VERA.”
  • Vera’s lead candidate atacicept is a fusion protein to treat IgA nephropathy that recently went through Phase 2a trials.
  • IgAN, also known as Berger’s disease, can lead to inflammatory tissue damage and kidney failure.
  • In its initial S-1 filing seeking as much as $86.25 million, Vera said it would use between $30 million and $35 million to complete its Phase 2b trials, and another $15 million to $20 million to initiate a Phase 2b or Phase 3 trial for patients with lupus nephritis.
  • The company said the proceeds would be able to fund operations for the next 18 months.
  • In 2009, the drug was licensed to Merck KGaA MKGAF, but most of the trials came up short to treat multiple sclerosis, lupus, and rheumatoid arthritis.
  • Last November, shortly after the German pharma announced the successful Phase IIa data for patients with IgAN, Vera licensed the drug for a 10% equity stake and about $733 million in milestones.

Posted In: Berger's diseaseBriefsgene therapyBiotechNewsHealth CareOfferingsIPOsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.